kabutan

Chordia Therapeutics, Sep-May (Cumulative 3Q) Net Income Loss Widens, Mar-May Net Income Loss Widens

Mon Jul 14, 2025 11:30 am JST Earnings

190A Chordia Therapeutics Inc. 【J-GAAP】

Earnings Report

Chordia Therapeutics Inc. <190A> [TSE Growth] announced its financial results at noon (11:30) on July 14th. The net loss (non-consolidated) for the cumulative third quarter of the fiscal year ending August 2025 (September 2024 to May 2025) expanded to a loss of 1.39 billion yen (compared to a loss of 1.17 billion yen in the same period last year).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the net loss for the June to August period (4Q) is expected to expand to a loss of 0.98 billion yen (compared to a loss of 0.65 billion yen in the same period last year).

In the most recent three-month period, from March to May (3Q), the net loss expanded to loss of 0.42 billion yen (compared to a loss of 0.37 billion yen in the same period last year).

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Sep - May, 2023 0 -1,180 -1,175 -1,177 -20.9 Jul 16, 2024 J-GAAP
Sep - May, 2024 0 -1,420 -1,397 -1,399 -20.4 Jul 14, 2025 J-GAAP
YoY -20.3% -18.9% -18.9% +2.1%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar - Aug, 2024 0 -992 -1,023 -1,025 -17.5 0 Oct 11, 2024 J-GAAP
Mar - Aug, 2025 Guidance -1,438 -1,403 -1,404 -20.4 0 Apr 11, 2025 J-GAAP
YoY -45.0% -37.1% -37.0% -16.6%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2024 0 -1,801 -1,824 -1,827 -31.1 0 Oct 11, 2024 J-GAAP
Aug, 2025 Guidance -2,434 -2,378 -2,380 -34.5 0 Oct 11, 2024 J-GAAP
YoY -35.1% -30.4% -30.3% -10.9%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Mar - May, 2024 0 -371 -374 -375 -6.7 -Inf Jul 16, 2024 J-GAAP
Jun - Aug, 2024 0 -621 -649 -650 -11.1 -Inf Oct 11, 2024 J-GAAP
Sep - Nov, 2024 0 -624 -615 -616 -9.1 -Inf Jan 14, 2025 J-GAAP
Dec - Feb, 2024 0 -372 -360 -360 -5.3 -Inf Apr 11, 2025 J-GAAP
Mar - May, 2025 0 -424 -422 -423 -6.2 -Inf Jul 14, 2025 J-GAAP
YoY -14.3% -12.8% -12.8% +7.1%

Related Articles